Mycenax Biotech Inc. (TPEX:4726)
Taiwan · Delayed Price · Currency is TWD 31.80
-0.70 (-2.15%)
Mar 4, 2026, 9:20 AM CST
Mycenax Biotech Market Cap
Mycenax Biotech has a market cap or net worth of 6.73 billion as of March 3, 2026. Its market cap has decreased by -18.32% in one year.
Market Cap
6.73B
Enterprise Value
7.64B
Revenue
649.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.80
Market Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 6.73B, an increase of 1,052.88%. That is a compound annual growth rate of 15.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 6.73B | 2.85% |
| Dec 31, 2025 | 6.55B | -26.98% |
| Dec 31, 2024 | 8.97B | 22.00% |
| Dec 29, 2023 | 7.35B | -4.53% |
| Dec 30, 2022 | 7.70B | 32.48% |
| Dec 30, 2021 | 5.81B | 40.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiGen Biopharmaceuticals Holdings | 8.72B |
| Acepodia | 7.83B |
| Adimmune | 7.59B |
| Savior Lifetec | 5.93B |
| Sinphar Pharmaceutical | 5.83B |
| CHO Pharma | 5.62B |
| AnnJi Pharmaceutical | 5.60B |
| Locus Cell | 5.40B |